The Human Medicines Regulations 2012 – …

The Human Medicines Regulations 2012 – description of each Part This document provides a brief overview of each Part of the Human Medicines Regulations 2012 …

  Human, Regulations, Descriptions, Medicine, 2012, Human medicines regulations 2012, Human medicines regulations 2012 description of

FULTIUM -D 800 IU CAPSULES - GOV.UK

Vitamin D deficiency, with levels of 25(OH)D below 25nmol/L (10ng/ml), could result in the disease rickets (or osteomalacia). The disease resulting as a deficiency is considered to be due to malabsorption

  Deficiency, Capsule, Vitamin, Fultium d 800 iu capsules, Fultium, Vitamin d deficiency

Meloxicam - GOV.UK

PL 31388/0003-4 UKPAR Alpex Pharma (UK) Ltd, Meloxicam 7.5mg and 15mg Orodispersible Tablets 3 Scientific Discussion INTRODUCTION Based on the review of the data on quality, safety and efficacy, the UK granted

  15mg, Meloxicam

PL 00010/0643 - GOV.UK

UKPAR Canesten HC Cream PL 00010/0643 6 All excipients comply with their respective European Pharmacopoeia monographs, except triceteareth-4-

  Excipients, 3460, Pl 00010 0643, 00010

Public Assessment Report UKPAR Canesten Combi …

This is a summary of the Public Assessment Report (PAR) for Canesten Combi Pessary & External Cream 500mg / 2% w/w pessary & cream (PL 00010/0653).

DCPAR for Ampicillin-Salbactam 1 g--0 5 and 2 g-1 g ...

PAR Ampicillin/Sulbactam 1 g/0.5 g and 2 g/1 g powder for Solution for Injection or Infusion UK/H/4322/001-2/DC 1 Public Assessment Report Decentralised Procedure

  Solutions

Public Assessment Report Mutual Recognition …

PAR Sayana 104mg/0.65ml Suspension for Injection UK/H/0960/001/MR 1 Public Assessment Report Mutual Recognition Procedure SAYANA 104MG/0.65ML SUSPENSION FOR INJECTION

  Assessment, Report, Public, Procedures, Mutual, Recognition, Public assessment report mutual recognition, Public assessment report mutual recognition procedure

Cefixime 400 mg Film-coated Tablets, PL 22805 …

MHRA PAR; CEFIXIME 400 MG FILM-COATED TABLETS, PL 22805/0032-3 2 Lay summary The Medicines and Healthcare products Regulatory Agency …

  Cefixime

Public Assessment Report Decentralised Procedure …

Public Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC

  Assessment, Report, Public, Procedures, Public assessment report decentralised procedure, Decentralised

Perindopril/Indapamide 2mg/0.625mg and …

UKPAR Perindopril/Indapamide 2mg/0.625 and 4mg/1.25mg Tablets PL 20092/0058-9 2 Perindopril/Indapamide 2mg/0.625mg and 4mg/1.25mg Tablets PL 20092/0058-9

  Perindopril, Perindopril indapamide, Indapamide

TRIA 2015 0115 - I. B. Green

TRIA 15 0115 NOTICE – OFFER of TERRORISM COVERAGE NOTICE – DISCLOSURE of PREMIUM The Terrorism Insurance Act of 2002 and …

  Tria, 0115

T0115-2 - NJ Transit

Title: T0115-2.eps Author: Graphic Department Created Date: 7/17/2017 2:56:15 PM

  Transit, Nj transit, T0115 2, T0115

Engineering Competency Model - DRAFT

Employment and Training Administration United States Department of Labor www.doleta.gov Engineering Competency Model - DRAFT 2 Table of Contents

  Draft, Model, Competency, Engineering, Engineering competency model draft

Briefing note: Prosecution of Health and Safety …

TRIM 2015/23633 Briefing note: Prosecution of Health and Safety Offences by HSE in Scotland Purpose To provide a summary of the main differences in legal system and HSE’s operational

  Notes, Health, Safety, Briefing, Briefing note, Prosecution of health and safety, Prosecution

CAP ON LOSSES FROM CERTIFIED ACTS OF …

X-19 (1/15) Includes material copyrighted by Insurance Services Office, Inc. THIS ENDORSEMENT CHANGES THE POLICY. PLEASE READ CAREFULLY . CAP ON LOSSES FROM CERTIFIED ACTS OF TERRORISM

  Form, Certified, Losses, Acts, On losses from certified acts of

Clinical Summary 2.7.4 SUMMARY OF CLINICAL …

CONFIDENTIAL CTD Module 2 Section 2-7-4_Summary of Clinical Safety, Page 1 Module 2.7 : Clinical Summary 2.7.4 SUMMARY OF CLINICAL SAFETY TABLE OF CONTENTS